Hepatocyte growth factor incorporated into herpes simplex virus vector accelerates facial nerve regeneration after crush injury

Gene Therapy

Volumn 18, Issue 11, 2011, Pages 1063-1069

  Esaki, S ^a,b   Kitoh, J ^c   Katsumi, S ^a   Goshima, F ^b   Kimura, H ^b   Safwat, M ^a   Yamano, K ^a   Watanabe, N ^a   Nonoguchi, N ^d   Nakamura, T ^e   Coffin, R S ^f   Miyatake, S I ^d   Nishiyama, Y ^b   Murakami, S ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA MEDICAL COLLEGE   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

facial nerve injury; hepatocyte growth factor; HSV

Indexed keywords

HERPESVIRUS VECTOR; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOKED MUSCLE RESPONSE; FACIAL NERVE INJURY; FEMALE; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE COMPRESSION; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; FACIAL NERVE; FACIAL NERVE INJURIES; GENE THERAPY; GENETIC VECTORS; HEPATOCYTE GROWTH FACTOR; MICE; NERVE COMPRESSION SYNDROMES; NERVE REGENERATION; SIMPLEXVIRUS;

MURINAE; MUS; SIMPLEXVIRUS;

EID: 80855132861     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2011.57     Document Type: Article

References (48)

1. Sendtner M, Kreutzberg GW, Thoenen H. Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 1990; 345: 440-441.
2. Koliatsos VE, Cayouette MH, Berkemeier LR, Clatterbuck RE, Price DL, Rosenthal A. Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons. Proc Natl Acad Sci USA 1994; 91: 3304-3308. (Pubitemid 24130225)
3. Hughes RA, Sendtner M, Thoenen H. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J Neurosci Res 1993; 36: 663-671. (Pubitemid 24002991)
4. Sendtner M, Dittrich F, Hughes RA, Thoenen H. Actions of CNTF and neurotrophins on degenerating motoneurons: preclinical studies and clinical implications. J Neurol Sci 1994; 124 (Suppl): 77-83.
5. Spector JG, Lee P, Derby A, Frierdich GE, Neises G, Roufa DG. Rabbit facial nerve regeneration in NGF-containing silastic tubes. Laryngoscope 1993; 103: 548-558. (Pubitemid 23136182)
6. Li L, Oppenheim RW, Lei M, Houenou LJ. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J Neurobiol 1994; 25: 759-766. (Pubitemid 24191245)
7. Barras FM, Pasche P, Bouche N, Aebischer P, Zurn AD. Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat. J Neurosci Res 2002; 70: 746-755. (Pubitemid 35416891)
8. Kohmura E, Yuguchi T, Yoshimine T, Fujinaka T, Koseki N, Sano A et al. BDNF atelocollagen mini-pellet accelerates facial nerve regeneration. Brain Res 1999; 849: 235-238.
9. Mohiuddin L, Delcroix JD, Fernyhough P, Tomlinson DR. Focally administered nerve growth factor suppresses molecular regenerative responses of axotomized peripheral afferents in rats. Neuroscience 1999; 91: 265-271. (Pubitemid 29170464)
10. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459. (Pubitemid 14073577)
11. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443. (Pubitemid 19277521)
12. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804. (Pubitemid 21926175)
13. Hayashi K, Morishita R, Nakagami H, Yoshimura S, Hara A, Matsumoto K et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Therapy 2001; 8: 1167-1173. (Pubitemid 32776390)
14. Caton A, Hacker A, Naeem A, Livet J, Maina F, Bladt F et al. The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons. Development 2000; 127: 1751-1766. (Pubitemid 30234931)
15. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res 1996; 43: 554-564. (Pubitemid 26087390)
16. Jin H, Yang R, Li W, Ogasawara AK, Schwall R, Eberhard DA et al. Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction. J Pharmacol Exp Ther 2003; 304: 654-660. (Pubitemid 36152341)
17. Maina F, Klein R. Hepatocyte growth factor, a versatile signal for developing neurons. Nat Neurosci 1999; 2: 213-217. (Pubitemid 30491290)
18. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997; 239: 639-644. (Pubitemid 27504153)
19. Sun W, Funakoshi H, Nakamura T. Overexpression of HGF retards disease progression and prolongs life span in a transgenic mouse model of ALS. J Neurosci 2002; 22: 6537-6548. (Pubitemid 35386410)
20. Sun W, Funakoshi H, Nakamura T. Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res Mol Brain Res 2002; 103: 36-48. (Pubitemid 34775032)
21. Kitamura K, Iwanami A, Nakamura M, Yamane J, Watanabe K, Suzuki Y et al. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 2007; 85: 2332-2342. (Pubitemid 47204748)
22. Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, Waguri S et al. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 2004; 109: 424-431. (Pubitemid 38133914)
23. Shimamura M, Sato N, Waguri S, Uchiyama Y, Hayashi T, Iida H et al. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension 2006; 47: 742-751. (Pubitemid 43740247)
24. Carnicero E, Knipper M, Tan J, Alonso MT, Schimmang T. Herpes simplex virus type 1-mediated transfer of neurotrophin-3 stimulates survival of chicken auditory sensory neurons. Neurosci Lett 2002; 321: 149-152. (Pubitemid 34203821)
25. Chattopadhyay M, Goss J, Wolfe D, Goins WC, Huang S, Glorioso JC et al. Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain 2004; 127: 929-939. (Pubitemid 38478536)
26. Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF et al. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Therapy 2007; 14: 1344-1352. (Pubitemid 47365620)
27. Kato R, Wolfe D, Coyle CH, Wechuck JB, Tyagi P, Tsukamoto T et al. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy 2009; 16: 26-33.
28. Walwyn WM, Matsuka Y, Arai D, Bloom DC, Lam H, Tran C et al. HSV-1-mediated NGF delivery delays nociceptive deficits in a genetic model of diabetic neuropathy. Exp Neurol 2006; 198: 260-270. (Pubitemid 43243764)
29. Coffin RS, MacLean AR, Latchman DS, Brown SM. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Therapy 1996; 3: 886-891. (Pubitemid 26348342)
30. Coffin RS, Thomas SK, Thomas DP, Latchman DS. The herpes simplex virus 2 kb latency associated transcript (LAT) leader sequence allows efficient expression of downstream proteins which is enhanced in neuronal cells: possible function of LAT ORFs. J Gen Virol 1998; 79 (Part 12): 3019-3026. (Pubitemid 29002338)
31. Palmer JA, Branston RH, Lilley CE, Robinson MJ, Groutsi F, Smith J et al. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system. J Virol 2000; 74: 5604-5618. (Pubitemid 30346595)
32. Lilley CE, Branston RH, Coffin RS. Herpes simplex virus vectors for the nervous system. Curr Gene Ther 2001; 1: 339-358.
33. Lindsay RM. Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview. Philos Trans R Soc Lond B Biol Sci 1996; 351: 365-373. (Pubitemid 126745342)
34. Federoff HJ, Geschwind MD, Geller AI, Kessler JA. Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci USA 1992; 89: 1636-1640.
35. Gravel C, Gotz R, Lorrain A, Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons. Nat Med 1997; 3: 765-770. (Pubitemid 27298721)
36. Hadlock TA, Heaton J, Cheney M, Mackinnon SE. Functional recovery after facial and sciatic nerve crush injury in the rat. Arch Facial Plast Surg 2005; 7: 17-20. (Pubitemid 43973836)
37. Most SP. Facial nerve recovery in bcl2 overexpression mice after crush injury. Arch Facial Plast Surg 2004; 6: 82-87.
38. Serpe CJ, Sanders VM, Jones KJ. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice. J Neurosci Res 2000; 62: 273-278.
39. Esslen E. A method of demonstrating and measuring disturbances of central innervation: electrotonomyography. Electroencephalogr Clin Neurophysiol 1967; 23: 387.
40. Honda N, Hato N, Takahashi H, Wakisaka H, Kisaki H, Murakami S et al. Pathophysiology of facial nerve paralysis induced by herpes simplex virus type 1 infection. Ann Otol Rhinol Laryngol 2002; 111: 616-622. (Pubitemid 34760809)
41. Engstrom M, Jonsson L, Grindlund M, Stalberg E. House-Brackmann and Yanagihara grading scores in relation to electroneurographic results in the time course of Bell's palsy. Acta Otolaryngol 1998; 118: 783-789. (Pubitemid 28545346)
42. Sugita T, Murakami S, Yanagihara N, Fujiwara Y, Hirata Y, Kurata T. Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis. Ann Otol Rhinol Laryngol 1995; 104: 574-581.
43. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124: 27-30. (Pubitemid 26019621)
44. Nishiyama Y. Herpes simplex virus gene products: the accessories reflect her lifestyle well. Rev Med Virol 2004; 14: 33-46. (Pubitemid 38133624)
45. Komobuchi H, Hato N, Teraoka M, Wakisaka H, Takahashi H, Gyo K et al. Basic fibroblast growth factor combined with biodegradable hydrogel promotes healing of facial nerve after compression injury: an experimental study. Acta Otolaryngol 2010; 130: 173-178.
46. Zhao MZ, Nonoguchi N, Ikeda N, Watanabe T, Furutama D, Miyazawa D et al. Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector. J Cereb Blood Flow Metab 2006; 26: 1176-1188. (Pubitemid 44268180)
47. Liu Y, Michalopoulos GK, Zarnegar R. Molecular cloning and characterization of cDNA encoding mouse hepatocyte growth factor. Biochim Biophys Acta 1993; 1216: 299-303. (Pubitemid 23344133)
48. Esaki S, Goshima F, Katsumi S, Watanabe D, Ozaki N, Murakami S et al. Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo. Arch Virol 2010; 155: 1235-1245.